Text Size

"Iatrogenesis Imperfecta"- Extent and Characteristic in NICU in Israel.

This study has been completed.
Sponsor:
Information provided by:
Bnai Zion Medical Center
ClinicalTrials.gov Identifier:
NCT00264563
First received: December 12, 2005
Last updated: June 16, 2011
Last verified: August 2005
History of Changes
  Purpose

Iatrogenesis is inevitable in the NICUs.


Condition Intervention Phase
Iatrogenesis in NICU
 Behavioral: Increasing the level of awareness to Iatrogenesis
Behavioral: Increasing awareness .
 Phase 1

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Further study details as provided by Bnai Zion Medical Center:

Estimated Enrollment: 750
Study Start Date: November 2005
Estimated Study Completion Date: April 2006
Groups/Cohorts Assigned Interventions
Behavioral
The intervention is basically by letting the care givers to be aware that there is active recording of iatrogenesis
 Behavioral: Increasing the level of awareness to Iatrogenesis
Increasing the level of awareness to Iatrogenesis
Behavioral: Increasing awareness .
Increasing awareness to Iatrogenesis and active daily recordings
Other Name: In the first 3 months the medical teams were unaware of recordings while in next 3 months they became aware to recordings

Detailed Description:

In the first 3 months of the study we will document Iatrogenic events in 3 NICUs in Israel without informing the medical and nursing staff. In the second 3 months of the study we will try to draw the attention of the medical and nursing staff that we are documenting iatogenesis, and we will assess wether this intervention will decrease the events of Iatrogenesis.

  Eligibility

Ages Eligible for Study:   up to 6 Months
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Ifants admitted to NICU during the study period

Criteria

Inclusion Criteria:All infants in NICU -

Exclusion Criteria:None

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00264563

Locations
Israel
Bnai Zion Medical Center
Haifa, Israel
Bnai Zion Medical Center, Rambam Medical Center, Barzilay Medical Center
Haifa ans Ashkelon, Israel, 31048
Sponsors and Collaborators
Bnai Zion Medical Center
Investigators
Principal Investigator: Amir Kugelman Senior Neonatologist
  More Information

No publications provided

Responsible Party: Amir Kugelman, Bnai Zion Medical Center
ClinicalTrials.gov Identifier: NCT00264563     History of Changes
Other Study ID Numbers: 80/05
Study First Received: December 12, 2005
Last Updated: June 16, 2011
Health Authority: Israel: Ministry of Health
United States: Food and Drug Administration

ClinicalTrials.gov processed this record on June 18, 2013